JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB283958

Anti-SARS-COV-2 nsp3 抗体 [EPR24842-84]

Anti-SARS-COV-2 nsp3 antibody [EPR24842-84]

3

(3 Reviews)

|

(2 Publications)

Rabbit Recombinant Monoclonal R1AB antibody. Suitable for ELISA, WB and reacts with SARS-CoV-2 samples. Cited in 2 publications.

別名を表示する

1a-1b, rep, Replicase polyprotein 1ab, pp1ab, ORF1ab polyprotein

3 Images
ELISA - Anti-SARS-COV-2 nsp3 antibody [EPR24842-84] (AB283958)
  • ELISA

Lab

ELISA - Anti-SARS-COV-2 nsp3 antibody [EPR24842-84] (AB283958)

Indirect ELISA showing primary antibody ab283958 binding to recombinant SARS-COV-2 NSP3 protein (His-tag). Plates were coated with recombinant SARS-COV-2 NSP3 protein (His-tag) and recombinant SARS-COV-2 NSP9 protein (His-tag) at 1000 ng/ml. Binding of ab283958 was assessed in a serial dilution range 0.016- 1000 ng/mL (a 3-fold serial dilution).

Binding was detected using pre-adsorbed secondary antibody, goat anti-rabbit IgG H&L (HRP, ab97080) at 1/2000 dilution.

Western blot - Anti-SARS-COV-2 nsp3 antibody [EPR24842-84] (AB283958)
  • WB

Lab

Western blot - Anti-SARS-COV-2 nsp3 antibody [EPR24842-84] (AB283958)

All lanes : Anti-SARS-CoV2 NSP3 antibody (ab283958) at 1/1000 dilution

Lanes 1-2 : Recombinant SARS-CoV2 NSP3 protein (His tagged) at 0.4 μg

Lanes 1 : Red – loading control ab18184 (Mouse monoclonal [HIS.H8] to 6X His tag®) observed at 21 kDa.

Lanes 2 : Green – ab283958 observed at 21 kDa

ab283958 was shown to bind specifically to SARS-CoV-2 NSP3 protein in Western blot. Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

Blocking buffer : 3% milk in TBS-0.1% Tween® 20 (TBS-T)

All lanes:

Western blot - Anti-SARS-COV-2 nsp3 antibody [EPR24842-84] (ab283958)

Observed band size: 21 kDa

false

Western blot - Anti-SARS-COV-2 nsp3 antibody [EPR24842-84] (AB283958)
  • WB

AbReview80462****

Western blot - Anti-SARS-COV-2 nsp3 antibody [EPR24842-84] (AB283958)

All lanes:

Western blot - Anti-SARS-COV-2 nsp3 antibody [EPR24842-84] (ab283958) at 1 µg/mL

Lane 1:

Precision Plus Protein™ Dual Color Standard.

Lane 2:

CaCo2 Uninfected whole cell lysate, at 40 µg

Lane 3:

CaCo2 infected with SARS-CoV-2 whole cell lysate at 40 µg

Lane 4:

CaCo2 infected with CoV-NL63 whole cell lysate at 40 µg

Lane 5:

CaCo2 infected with CoV-OC463 whole cell lysate at 40 µg

Lane 6:

recombinant SARS CoV-2 NSP-3 + GST tag, at 1 µg

Lane 7:

A549 WT whole cell lysate at 15 µg

Secondary

All lanes:

LiCor goat anti-rabbit 800CW

false

This image is courtesy of an Abreview submitted by Nicola Goodman

関連する標識済み抗体及び組成の異なる製品 (1)

  • Carrier free

    Anti-SARS-COV-2 nsp3 antibody [EPR24842-84] - BSA and Azide free

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR24842-84

アイソタイプ

IgG

キャリアフリー

No

交差種

SARS-CoV-2

アプリケーション

WB, ELISA

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "SARS-CoV-2": { "ELISA-species-checked": "testedAndGuaranteed", "ELISA-species-dilution-info": "0.00002-1 µg/mL", "ELISA-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" } } }

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

The SARS-CoV-2 nonstructural protein 3 commonly known as nsp3 plays an important role in the replication-transcription complex of the virus. Its mass is approximately 213 kDa. This multi-functional protein is expressed in infected host cells where it is involved in processes essential for viral replication. Nsp3 includes several functional domains such as a papain-like protease and ADP-ribose-1ʹ-phosphatase enabling it to process viral polypeptides and interfere with host cellular processes.
Biological function summary

Nsp3 is critical in the formation of the replication complex where it collaborates with other nonstructural proteins like nsp4 and nsp6. These interactions facilitate the modification of host cell membranes creating a conducive environment for viral RNA synthesis. In addition nsp3's enzymatic activity is necessary for inhibiting host immune responses supporting the virus's ability to establish infection within a host.

Pathways

Nsp3 participates in the viral life cycle by influencing key pathways including the autophagy pathway and translation initiation. Nsp3 can modulate the host's autophagy which typically helps in degrading cellular components to favor viral replication. Additionally nsp3 interferes with translation initiation affecting the host's ability to synthesize proteins therefore aiding in the initiation of viral protein synthesis. It cooperates with proteins like nsp5 and nsp12 in these pathways further ensuring efficient production of viral components.

Nsp3 is directly linked to COVID-19 the disease caused by SARS-CoV-2. This protein's ability to manipulate the host immune response highlights its significance in exacerbating the inflammatory response seen in severe cases. Nsp3 also connects to cytokines which are elevated during hyperinflammatory responses contributing to the pathophysiology of the disease. Additional insights into nsp3's functions can aid in the development of therapeutic strategies targeting COVID-19.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Replicase polyprotein 1ab. Multifunctional protein involved in the transcription and replication of viral RNAs. Contains the proteinases responsible for the cleavages of the polyprotein.. Host translation inhibitor nsp1. Inhibits host translation by associating with the open head conformation of the 40S subunit (PubMed : 32680882, PubMed : 32908316, PubMed : 33080218, PubMed : 33479166). The C-terminus binds to and obstructs ribosomal mRNA entry tunnel (PubMed : 32680882, PubMed : 32908316, PubMed : 33080218, PubMed : 33479166). Thereby inhibits antiviral response triggered by innate immunity or interferons (PubMed : 32680882, PubMed : 32979938, PubMed : 33080218). The nsp1-40S ribosome complex further induces an endonucleolytic cleavage near the 5'UTR of host mRNAs, targeting them for degradation (By similarity). This inhibits the integrated stress response (ISR) in the infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream of stress granule formation and depletes host G3BP1 (PubMed : 36534661). Viral mRNAs less susceptible to nsp1-mediated inhibition of translation, because of their 5'-end leader sequence (PubMed : 32908316, PubMed : 33080218).. Non-structural protein 2. Enhances mRNA repression of the 4EHP-GYF2 complex in the host, thereby inhibiting the antiviral response and facilitating SARS-CoV-2 replication. Possibly acts in cooperation with nsp1, which induces ribosome stalling on host mRNA, triggering mRNA repression by the host 4EHP-GYF2 complex which is enhanced by nsp2.. Papain-like protease nsp3. Responsible for the cleavages located at the N-terminus of the replicase polyprotein. Participates together with nsp4 in the assembly of virally-induced cytoplasmic double-membrane vesicles necessary for viral replication (PubMed : 35551511). Antagonizes innate immune induction of type I interferon by blocking the phosphorylation, dimerization and subsequent nuclear translocation of host IRF3 (PubMed : 32733001). Also prevents host NF-kappa-B signaling (By similarity). In addition, PL-PRO possesses a deubiquitinating/deISGylating activity and processes both 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular substrates (PubMed : 32726803). Cleaves preferentially ISG15 from antiviral protein IFIH1 (MDA5), but not RIGI (PubMed : 33727702). Can play a role in host ADP-ribosylation by ADP-ribose (PubMed : 32578982). Plays a role in the formation and maintenance of double membrane vesicles (DMVs) replication organelles (PubMed : 35551511). DMVs are formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects to lipid droplets (PubMed : 35551511).. Non-structural protein 4. Plays a role in the formation and maintenance of double membrane vesicles (DMVs) replication organelles (PubMed : 35551511). DMVs are formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects to lipid droplets (PubMed : 35551511).. 3C-like proteinase nsp5. Cleaves the C-terminus of replicase polyprotein at 11 sites (PubMed : 32321856). Recognizes substrates containing the core sequence [ILMVF]-Q-|-[SGACN] (PubMed : 32198291, PubMed : 32272481). Cleaves and inactivates human TRMT1, preventing tRNA guanine(26)-dimethylation of tRNAs (PubMed : 37073102, PubMed : 38814682, PubMed : 39773525). May cleave human NLRP1 in lung epithelial cells, thereby activating the NLRP1 inflammasome pathway (PubMed : 35594856). May cleave human GSDMD, triggering alternative GSDME-mediated epithelial cell death upon activation of the NLRP1 inflammasome, which may enhance the release interleukins 1B, 6, 16 and 18 (PubMed : 35594856). Also able to bind an ADP-ribose-1''-phosphate (ADRP) (PubMed : 32198291, PubMed : 32272481).. Non-structural protein 6. Plays a role in the formation and maintenance of double membrane vesicles (DMVs) replication organelles (PubMed : 35551511). DMVs are formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects to lipid droplets (PubMed : 35551511). LDs are consumed during DMV formation (PubMed : 35551511). Binds to host TBK1 without affecting TBK1 phosphorylation; the interaction with TBK1 decreases IRF3 phosphorylation, which leads to reduced IFN-beta production (PubMed : 32979938).. Non-structural protein 7. Plays a role in viral RNA synthesis (PubMed : 32277040, PubMed : 32358203, PubMed : 32438371, PubMed : 32526208). Forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers (By similarity).. Non-structural protein 8. Plays a role in viral RNA synthesis (PubMed : 32277040, PubMed : 32358203, PubMed : 32438371, PubMed : 32526208). Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers (By similarity). Interacts with ribosome signal recognition particle RNA (SRP) (PubMed : 33080218). Together with NSP9, suppress protein integration into the cell membrane, thereby disrupting host immune defenses (PubMed : 33080218).. Viral protein genome-linked nsp9. Forms a primer, NSP9-pU, which is utilized by the polymerase for the initiation of RNA chains (PubMed : 37794589). Interacts with ribosome signal recognition particle RNA (SRP) (PubMed : 33080218). Together with NSP8, suppress protein integration into the cell membrane, thereby disrupting host immune defenses (PubMed : 33080218).. Non-structural protein 10. Plays a pivotal role in viral transcription by stimulating both nsp14 3'-5' exoribonuclease (By similarity) and nsp16 2'-O-methyltransferase activities (PubMed : 35944563). Therefore plays an essential role in viral mRNAs cap methylation.. RNA-directed RNA polymerase nsp12. RNA-directed RNA polymerase that catalyzes the transcription of viral genomic and subgenomic RNAs. Acts in complex with nsp7 and nsp8 to transcribe both the minus and positive strands of genomic RNA (PubMed : 32277040, PubMed : 32358203, PubMed : 32438371, PubMed : 32526208). The kinase-like NiRAN domain of NSP12 attaches one or more nucleotides to the amino terminus of NSP9, forming a covalent RNA-protein intermediate that serves as transcription/replication primer (PubMed : 37794589). Subgenomic RNAs (sgRNAs) are formed by discontinuous transcription : The polymerase has the ability to pause at transcription-regulating sequences (TRS) and jump to the leader TRS, resulting in a major deletion (PubMed : 35706445). This creates a series of subgenomic RNAs that are replicated, transcribed and translated (PubMed : 35706445). In addition, Nsp12 is a subunit of the viral RNA capping enzyme that catalyzes the RNA guanylyltransferase reaction for genomic and sub-genomic RNAs (PubMed : 35944563). Subsequently, the NiRAN domain transfers RNA to GDP, and forms the core cap structure GpppA-RNA (PubMed : 35944563).. Helicase nsp13. Plays a role in viral RNA synthesis (PubMed : 33232691). Multi-functional protein with a zinc-binding domain in N-terminus displaying RNA and DNA duplex-unwinding activities with 5' to 3' polarity. Activity of helicase is dependent on magnesium (By similarity). Binds to host TBK1 and inhibits TBK1 phosphorylation; the interaction with TBK1 decreases IRF3 phosphorylation, which leads to reduced IFN-beta production (PubMed : 32979938).. Guanine-N7 methyltransferase nsp14. Plays a role in viral RNA synthesis through two distinct activities. The N7-guanine methyltransferase activity plays a role in the formation of the cap structure GpppA-RNA (PubMed : 35944563). The proofreading exoribonuclease reduces the sensitivity of the virus to RNA mutagens during replication (By similarity). This activity acts on both ssRNA and dsRNA in a 3'-5' direction (By similarity).. Uridylate-specific endoribonuclease nsp15. Plays a role in viral transcription/replication and prevents the simultaneous activation of host cell dsRNA sensors, such as MDA5/IFIH1, OAS, and PKR (By similarity). Acts by degrading the 5'-polyuridines generated during replication of the poly(A) region of viral genomic and subgenomic RNAs (PubMed : 33504779, PubMed : 33564093). Catalyzes a two-step reaction in which a 2'3'-cyclic phosphate (2'3'-cP) is first generated by 2'-O transesterification, which is then hydrolyzed to a 3'-phosphate (3'-P) (PubMed : 33504779, PubMed : 33564093). If not degraded, poly(U) RNA would hybridize with poly(A) RNA tails and activate host dsRNA sensors (By similarity). May bind genomic dsRNA in association with the replication-transcription complex (RTC), and play a role in nsp12 discontinous transcription (PubMed : 34562452, PubMed : 35706445).. 2'-O-methyltransferase nsp16. Methyltransferase that mediates mRNA cap 2'-O-ribose methylation to the 5'-cap structure of viral mRNAs (PubMed : 35944563). N7-methyl guanosine cap is a prerequisite for binding of nsp16 (PubMed : 35944563). Therefore, it plays an essential role in cap methylation of viral mRNAs, which is essential to evade the immune system, especially when restricted by human IFIT1 and IFIT3 (PubMed : 35944563, PubMed : 36722972, PubMed : 36285486). May disrupt host mRNA splicing in nucleus by interacting with pre-mRNA Recognition Domains of the U1 and U2 snRNAs (PubMed : 33080218).
See full target information rep

文献 (2)

Recent publications for all applications. Explore the full list and refine your search

Nucleic acids research 53: PubMed40705924

2025

SARS-CoV-2 Nsp2 recruits GIGYF2 near viral replication sites and supports viral protein production.

Applications

Unspecified application

Species

Unspecified reactive species

Jimi Kim,Youngran Park,Doil Yoon,Sunghan Lee,Haedong Kim,Ka-Yun Ban,Jihye Yang,Da-Eun Choi,Jeesoo Kim,Jong-Seo Kim,V Narry Kim

Proceedings of the National Academy of Sciences of the United States of America 120:e2302083120 PubMed37607224

2023

SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Yousef M Alhammad,Srivatsan Parthasarathy,Roshan Ghimire,Catherine M Kerr,Joseph J O'Connor,Jessica J Pfannenstiel,Debarati Chanda,Caden A Miller,Nathalie Baumlin,Matthias Salathe,Robert L Unckless,Sonia Zuñiga,Luis Enjuanes,Sunil More,Rudragouda Channappanavar,Anthony R Fehr
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com